Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Thyroid Neoplasms × NVP-BKM120 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 8 Breast Neoplasms 8 Recurrence 3 Triple Negative Breast Neoplasms 2 Prostatic Neoplasms 2 Melanoma 2 Endometrial Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Brain Neoplasms 2 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Neoplasms 1 Lymphoma 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Glioblastoma 1 Esophageal Neoplasms 1 Disease Progression 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Basal Cell 1 Basal Cell Nevus Syndrome 1 Advanced Endometrial Cancer 1

Interventions

Sorafenib 8 lenvatinib 6 Everolimus 6 trametinib 5 dabrafenib 5 vandetanib 4 pembrolizumab 4 Sunitinib 4 Paclitaxel 4 Nivolumab 4 Magnetic Resonance Spectroscopy 4 Iodine-131 4 selpercatinib 3 apatinib 3 anlotinib 3 surufatinib 2 pazopanib 2 Vemurafenib 2 Triiodothyronine 2 Thyroxine 2 Thyrotropin Alfa 2 Surgical Procedures, Operative 2 Ipilimumab 2 Iodine-124 2 Doxorubicin 2 Docetaxel 2 Cyclophosphamide 2 Biopsy, Large-Core Needle 2 Axitinib 2 AZD 6244 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01830504 2016-10-05

BKM120

Hospices Civils de Lyon

Phase 2 Unknown

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡